Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret 

₺1.9800
23
+₺0.04+2.06%Friday 14:59

Statistics

Day High
2.12
Day Low
1.93
52W High
5.08
52W Low
1.84
Volume
34,040,223
Avg. Volume
25,951,959
Mkt Cap
990M
P/E Ratio
4.9
Dividend Yield
-
Dividend
-

Earnings

Nov 6Expected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q2 2020
Q3 2020
-0
0.21
0.43
0.65
Expected EPS
N/A
Actual EPS
0.344

Financials

367.83%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
239.56MRevenue
881.18MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RTALB.IS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a global biotechnology company that develops and manufactures biologic medicines, competing in the same biopharmaceutical space as RTALB.IS.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a large pharmaceutical company with a significant portfolio of biological drugs, competing directly with RTALB.IS in the biopharmaceutical market.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, including biological products, making it a competitor in the biologic and pharmaceutical industry.
Merck
MRK
Mkt Cap356.01B
Merck is a global healthcare company that offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, competing with RTALB.IS in the pharmaceutical and biologic sectors.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company with a strong emphasis on innovative medicines and biopharmaceuticals, competing in the same space as RTALB.IS.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a biopharmaceutical company that discovers, develops, and markets both biologic and small molecule drugs, making it a competitor in the biopharmaceutical industry.
Sanofi
SNY
Mkt Cap95.65B
Sanofi is a global biopharmaceutical company focused on human health, offering a range of medicines and vaccines, including biologics, competing with RTALB.IS.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including biologics, making it a competitor in the same industry.

About

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nucleic acid extraction kits, microbiology media, microbiology stains, and rapid tests; standards and reference materials, and membrane filters; chemicals and reactives, membrane filters, microbiology gas generators, and other consumables; and instruments and consumables. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. was incorporated in 1996 and is based in Kocaeli, Turkey.
Show More
CEO
Resat Ultav
Employees
73
Country
Turkey
ISIN
TRERTAL00018

Listings

0 Comments

Share your thoughts

FAQs

What is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret stock price today?▼
The current price of RTALB.IS is ₺1.98 TRY — it has increased by +2.06% in the past 24 hours. Watch Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret stock price performance more closely on the chart.
What is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Istanbul Stock Exchange exchange Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret stocks are traded under the ticker RTALB.IS.
Is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret stock price growing?▼
RTALB.IS stock has fallen by -5.71% compared to the previous week, the month change is a +0.51% rise, over the last year Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret has showed a -54.69% decrease.
What is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret market cap?▼
Today Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret has the market capitalization of 990M
What were Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret earnings last quarter?▼
RTALB.IS earnings for the last quarter are 0.34 TRY per share, whereas the estimation was N/A TRY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A TRY per share.
What is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret revenue for the last year?▼
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret revenue for the last year amounts to 239.56M TRY.
What is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret net income for the last year?▼
RTALB.IS net income for the last year is 881.18M TRY.
How many employees does Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret have?▼
As of November 1, 2026, the company has 73 employees.
In which sector is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret located?▼
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret operates in the Health & Wellness sector.
When did Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret complete a stock split?▼
The last stock split for Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret was on March 19, 2025 with a ratio of 400:100.
Where is Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret headquartered?▼
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makina Sanayi Ticaret is headquartered in Kocaeli, Turkey.